Trends in survival of Swedish men and women with heart failure from 1987 to 2014: a population-based case-control study
- PMID: 34784655
- PMCID: PMC8788029
- DOI: 10.1002/ehf2.13720
Trends in survival of Swedish men and women with heart failure from 1987 to 2014: a population-based case-control study
Abstract
Aims: To compare trends in short-term and long-term survival of patients with heart failure (HF) compared with controls from the general population.
Methods and results: We used data from the Swedish National Inpatient Registry to identify all patients aged ≥18 years with a first recorded diagnosis of HF between 1 January 1987 and 31 December 2014 and compared them with controls matched on age and sex from the Total Population Register. We included 702 485 patients with HF and 1 306 183 controls. In patients with HF aged 18-64 years, short-term (29 days to 6 months) and long-term mortality (>11 years) decreased from 166 and 76.6 per 1000 person-years in 1987 to 2000 to 99.6 and 49.4 per 1000 person-years, respectively, in 2001 to 2014. During the same period, mortality improved marginally, in those aged ≥65 years: short-time mortality from 368.8 to 326.2 per 1000 person-years and long-term mortality from 219.6 to 193.9 per 1000 person-years. In 1987-2000, patients aged <65 years had more than three times higher risk of dying at 29 days to 6 months, with an hazard ratio (HR) of 3.66 [95% confidence interval (CI) 3.46-3.87], compared with controls (P < 0.0001) but substantially higher in 2001-2014 with an HR of 11.3 (95% CI 9.99-12.7, P < 0.0001). HRs for long-term mortality (6-10 and >11 years) increased moderately from 2.49 (95% CI 2.41-2.57) and 3.16 (95% CI 3.07-3.24) in 1987-2000 to 4.35 (95% CI 4.09-4.63) and 4.11 (95% CI 3.49-4.85) in 2001-2014, largely because survival among controls improved more than that among patients with HF (P < 0.0001).
Conclusions: Absolute survival improved in HF patients aged <65 years, but only marginally so in those aged ≥65 years. Compared with controls, both short-term and long-term relative risk of dying increased, especially in younger patients with HF.
Keywords: Epidemiology; Heart failure; Mortality; Population; Survival; Trends.
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Conflict of interest statement
Lena Björck, Carmen Basic, Christina E. Lundberg, Tatiana Zverkova Sandström, Maria Schaufelberger, and Annika Rosengren declare that they have no conflict of interest.
Figures
References
-
- Ryder S, Fox K, Rane P, Armstrong N, Wei CY, Deshpande S, Stirk L, Qian Y, Kleijnen JA. A systematic review of direct cardiovascular event costs: an international perspective. Pharmacoeconomics 2019; 37: 895–919. - PubMed
-
- Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam study. Eur Heart J 2004; 25: 1614–1619. - PubMed
-
- Parén P, Schaufelberger M, Bjorck L, Lappas G, Fu M, Rosengren A. Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in Sweden. Eur J Heart Fail 2014; 16: 737–742. - PubMed
-
- Christiansen MN, Kober L, Weeke P, Vasan RS, Jeppesen JL, Smith JG, Gislason GH, Torp‐Pedersen C, Andersson C. Age‐specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation 2017; 135: 1214–1223. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
